Antibiotic Pipeline Profile: Targeting Delivery To Infection Site

Among the antibiotics that have garnered a qualified infectious disease product designation, a collection of late-stage products are targeted at local delivery, especially inhaled and vaginal formulations.

Illustration of bacteria on colorful background, model of bacteria, microbes, microorganisms,

Several antibiotic drug developers are looking to alternative delivery systems to offer localized delivery for anti-infective agents – such as inhaled formulations that target the lungs – a pathway that could result in new approvals for older molecules.

Pulmonary delivery technology that could make new products from generic antibiotics has attracted a range of respiratory-focused companies to the...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Scrip for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Anti-infective

More from Therapy Areas